Famed investor Warren Buffett loves Apple (NASDAQ:AAPL) stock, recently saying he'd "love to own 100% of it." But with Apple's total market cap recently surpassing $1 trillion, not even the Oracle of Omaha has that kind of money. But ever since first investing in Apple in 2016, Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) has steadily increased its holdings nearly every quarter since. The conglomerate is more aggressive in its purchases in some quarters, while more modest in others.
Berkshire just bought 12.4 million more shares in the second quarter, according to regulatory filings.
Apple CEO Tim Cook. Image source: Apple.
252 million shares and countingAfter scooping up another 12.4 million shares, Berkshire now owns nearly 252 million Apple shares. That position was worth approximately $46.6 billion at the end of the second quarter -- except shares have gained 13% since then, pegging the current value of Berkshire's position at roughly $52.9 billion at current levels.
Top Warren Buffett Stocks To Invest In Right Now: Devon Energy Corporation(DVN)
Advisors' Opinion:- [By Matthew DiLallo]
Meanwhile, Devon Energy (NYSE:DVN) and Hess (NYSE:HES) both started with smaller authorizations that they've since expanded. In Devon Energy's case, it initially set a $1 billion buyback program, which at the time was enough to retire 6% of its outstanding stock. However, after selling its midstream business, Devon added $3 billion to its authorization, giving it the cash to buy back 20% of its shares. Hess, meanwhile, started off with a $500 million buyback program last fall, which it boosted by $1 billion earlier this year, enough to retire about 10% of its shares at the time.
- [By Stephan Byrd]
These are some of the news headlines that may have impacted Accern Sentiment’s rankings:
Get Devon Energy alerts: Devon Energy (DVN) Presents At UBS Global Oil and Gas Conference – Slideshow (seekingalpha.com) Devon Energy (DVN) Receives Average Rating of “Buy” from Analysts (americanbankingnews.com) Top 5 Upstream Revenues: Higher Realized Prices Drive Growth (finance.yahoo.com) Comparing Stocks: COP, OXY, DVN, EOG, and APC (finance.yahoo.com) Free Research Report as Devon Energy's Quarterly Revenues Advanced 7.29% (finance.yahoo.com)NYSE:DVN traded down $1.11 during trading hours on Friday, hitting $40.58. The company had a trading volume of 6,948,699 shares, compared to its average volume of 7,939,727. The stock has a market cap of $21.24 billion, a P/E ratio of 64.41, a price-to-earnings-growth ratio of 4.37 and a beta of 2.16. Devon Energy has a 52 week low of $28.79 and a 52 week high of $45.16. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.70.
- [By ]
Devon Energy (DVN) : "They shot the lights out. They've got growth and are bigger than ever."
Discovery Communications (DISCA) : "I love this combination. "
- [By Jason Hall, Tyler Crowe, and John Bromels]
According to three Motley Fool contributors, there are still ample opportunities to profit in the oil and gas segment as some left-behind subsectors start to catch up to the higher price trend. Three in particular that are well-positioned going forward are Transocean LTD (NYSE:RIG), National-Oilwell Varco, Inc. (NYSE:NOV), and Devon Energy Corp (NYSE:DVN).
- [By Matthew DiLallo]
Shares of Devon Energy (NYSE:DVN) were in rally mode on Wednesday, surging more than 10% by 10:00 a.m. EST. Fueling the gains in the oil producer's stock were its fourth-quarter results.
- [By Jon C. Ogg]
Devon Energy Corp. (NYSE: DVN) is also a Buy, with a $47 price objective, and with its multiples based on a finite timeline to delivery that is also supported by its core NAV. Shares of Devon Energy were down 0.4% at $29.52.
Top Warren Buffett Stocks To Invest In Right Now: MannKind Corporation(MNKD)
Advisors' Opinion:- [By Keith Speights]
Three of the biggest winners were ProQR Therapeutics (NASDAQ:PRQR), MannKind Corp. (NASDAQ:MNKD), and Arrowhead Pharmaceuticals (NASDAQ:ARWR). Here's why these biotech stocks soared this week and a look at whether they're smart picks for investors now.
- [By Brian Feroldi]
Here's are some of the biggest and best-know publicly traded diabetes companies:
Company Ticker Market Cap Products Abbott Laboratories (NYSE: ABT) $126 billion Continuous glucose monitor AstraZeneca (NYSE: AZN) $95 billion Pharmaceuticals Becton, Dickinson (NYSE: BDX) $70 billion Diagnostic and delivery devices DexCom (NASDAQ:DXCM) $12.7 billion Continuous glucose monitor Eli Lilly (NYSE: LLY) $106 billion Insulin and pharmaceuticals Insulet (NASDAQ:PODD) $6.1 billion Insulin pump Johnson & Johnson (NYSE: JNJ) $375 billion Glucose monitor and pharmaceuticals Lexicon Pharmaceuticals (NASDAQ: LXRX) $1.2 billion Pharmaceuticals MannKind (NASDAQ: MNKD) $291 million Inhaled insulin Medtronic (NYSE: MDT) $133 billion Insulin pumps and continuous glucose monitor Novo Nordisk (NYSE:NVO) $116 billion Insulin and pharmaceuticals Sanofi (NYSE: SNY) $108 billion Insulin and pharmaceuticals Senseonics Holdings (NYSEMKT: SENS) $834 million Continuous glucose monitorDATA SOURCE: YAHOO! FINANCE. MARKET CAP DATA AS OF 9/25/2018.
- [By Dan Caplinger]
Wednesday was a mixed day on Wall Street, with most major benchmarks easing lower as market participants continued to seek clarity on the trade front. Until negotiations with key partners like Canada and China come to a conclusion, some investors remain nervous about the possible ramifications of a failure to get deals completed. Yet in the absence of any outright negative news, trade-related or otherwise, the market has resisted substantial declines, rebounding from temporary setbacks. Positive sentiment around some key individual stocks has helped to buoy enthusiasm generally. Cronos Group (NASDAQ:CRON), MannKind (NASDAQ:MNKD), and Vera Bradley (NASDAQ:VRA) were among the best performers on the day. Here's why they did so well.
- [By Brian Feroldi]
MannKind (NASDAQ:MNKD) was founded in 2001 with a simple mission: to make treating chronic and acute diseases easier. The company's big idea was to develop technology that enabled drugs to be inhaled through the lungs instead of needing to be injected through the skin.
- [By Logan Wallace]
Get a free copy of the Zacks research report on MannKind (MNKD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By George Budwell]
MannKind Corporation (NASDAQ:MNKD), the maker of the inhaled insulin product Afrezza, had yet another bad month in April. Specifically, the biotech's shares lost a quarter of their value last month, according to S&P Global Market Intelligence.
Top Warren Buffett Stocks To Invest In Right Now: BlackRock Utility and Infrastructure Trust(BUI)
Advisors' Opinion:- [By Ethan Ryder]
Media stories about Blackrock Utlts Infra&Pwr Oprtnt Trst (NYSE:BUI) have trended somewhat negative this week, Accern reports. The research group identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blackrock Utlts Infra&Pwr Oprtnt Trst earned a media sentiment score of 0.00 on Accern’s scale. Accern also gave headlines about the real estate investment trust an impact score of 47.3004100251897 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
- [By Ethan Ryder]
News headlines about Blackrock Utlts Infra&Pwr Oprtnt Trst (NYSE:BUI) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Blackrock Utlts Infra&Pwr Oprtnt Trst earned a news impact score of 0.00 on Accern’s scale. Accern also assigned news articles about the real estate investment trust an impact score of 47.4349959781156 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
- [By Logan Wallace]
Blackrock Utlts Infra&Pwr Oprtnt Trst (NYSE:BUI) announced a monthly dividend on Monday, October 1st, NASDAQ reports. Shareholders of record on Monday, October 15th will be paid a dividend of 0.121 per share by the real estate investment trust on Wednesday, October 31st. This represents a $1.45 dividend on an annualized basis and a yield of 7.26%. The ex-dividend date is Friday, October 12th.
- [By Joseph Griffin]
Blackrock Utlts Infra&Pwr Oprtnt Trst (NYSE:BUI) declared a monthly dividend on Wednesday, August 1st, NASDAQ reports. Investors of record on Wednesday, August 15th will be given a dividend of 0.121 per share by the real estate investment trust on Friday, August 31st. This represents a $1.45 annualized dividend and a yield of 7.02%. The ex-dividend date of this dividend is Tuesday, August 14th.
- [By Logan Wallace]
Raymond James Financial Services Advisors Inc. lifted its position in shares of Blackrock Utlts Infra&Pwr Oprtnt Trst (NYSE:BUI) by 23.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 41,436 shares of the real estate investment trust’s stock after buying an additional 7,911 shares during the quarter. Raymond James Financial Services Advisors Inc. owned approximately 0.24% of Blackrock Utlts Infra&Pwr Oprtnt Trst worth $829,000 at the end of the most recent quarter.
Top Warren Buffett Stocks To Invest In Right Now: Cadiz, Inc.(CDZI)
Advisors' Opinion:- [By Max Byerly]
Odey Asset Management Group Ltd lessened its holdings in Cadiz Inc (NASDAQ:CDZI) by 18.8% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,026,450 shares of the company’s stock after selling 237,913 shares during the quarter. Cadiz makes up 1.3% of Odey Asset Management Group Ltd’s holdings, making the stock its 15th largest holding. Odey Asset Management Group Ltd’s holdings in Cadiz were worth $13,446,000 as of its most recent SEC filing.
- [By Joseph Griffin]
Cadiz (NASDAQ: CDZI) is one of 15 publicly-traded companies in the “Water supply” industry, but how does it contrast to its rivals? We will compare Cadiz to similar companies based on the strength of its valuation, profitability, institutional ownership, analyst recommendations, earnings, risk and dividends.
- [By Joseph Griffin]
Cadiz (NASDAQ:CDZI) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Saturday.
- [By Ethan Ryder]
Middlesex Water (NASDAQ: MSEX) and Cadiz (NASDAQ:CDZI) are both small-cap utilities companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, profitability and risk.
No comments:
Post a Comment